Talus Bioscience is focused on unlocking the regulome for drug discovery, utilizing proprietary technology to measure and modulate gene expression in its native context. Their platform enables the design of interventions at the root of cellular decision making, with a pipeline targeting previously undruggable targets in oncology, rare diseases, and immune dysfunction.

Talus Bioscience is focused on unlocking the regulome for drug discovery, utilizing proprietary technology to measure and modulate gene expression in its native context. Their platform enables the design of interventions at the root of cellular decision making, with a pipeline targeting previously undruggable targets in oncology, rare diseases, and immune dysfunction.